TGFB1 and pancreatic neoplasm: While reducing ALK4 expression did not consistently alter activin A- or Nodal-induced Smad2/3 phosphorylation, it significantly enhanced TGF-β1-mediated Smad2/3 phosphorylation in both breast and pancreatic cancer models (Fig. 4a–c).